Filing Details
- Accession Number:
- 0001203311-23-000012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-03 20:01:47
- Reporting Period:
- 2023-02-02
- Accepted Time:
- 2023-02-03 20:01:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1741836 | D Roger Dansey | 21823 30Th Drive Se Bothell WA 98021 | President, R&D & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-02-02 | 783 | $138.52 | 96,853 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 97 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2023.